Stocks › MRNA

Moderna, Inc.

MRNA·Nasdaq·United States United States·USD
$195.00
-4.33 (-2.17%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
MRNA
Moderna, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
MRNAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of MRNA by members of U.S. Congress · 77 on record · 15 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA MRNAModerna, Inc. · Stock Purchase
$1,001 - $15,000
Nov 10, 2026 Oct 20, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Stock Purchase
$1,001 - $15,000
Nov 5, 2026 Oct 13, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Stock Purchase
$1,001 - $15,000
Oct 8, 2026 Sep 11, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Common Stock Purchase
$1,001 - $15,000
Oct 8, 2026 Sep 4, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL MRNAModerna, Inc. · Stock Sale
$1,001 - $15,000
Oct 7, 2026 Sep 24, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL MRNAModerna, Inc. · Stock Sale
$1,001 - $15,000
Sep 9, 2026 Aug 19, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL MRNAModerna, Inc. · Stock Purchase
$1,001 - $15,000
Sep 9, 2026 Aug 19, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Stock Purchase
$1,001 - $15,000
Sep 5, 2026 Aug 24, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Stock Sale
$1,001 - $15,000
Sep 5, 2026 Aug 3, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Common Stock Purchase
$1,001 - $15,000
Jul 7, 2026 Jun 30, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Stock Sale
$1,001 - $15,000
Jun 10, 2026 May 1, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Stock Sale
$1,001 - $15,000
Jun 10, 2026 May 15, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Common Stock Purchase
$1,001 - $15,000
May 11, 2026 Apr 13, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Common Stock Purchase
$1,001 - $15,000
Feb 6, 2026 Jan 23, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Stock Sale
$1,001 - $15,000
Feb 6, 2026 Jan 29, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Stock Sale
$1,001 - $15,000
Sep 9, 2025 Aug 26, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · CMN Purchase
$1,001 - $15,000
Aug 7, 2025 Jul 25, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Stock Sale
$1,001 - $15,000
Jun 10, 2025 May 19, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Common Stock Sale
$1,001 - $15,000
May 12, 2025 Apr 10, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA MRNAModerna, Inc. · Stock Sale
$1,001 - $15,000
May 8, 2025 Apr 8, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA MRNAModerna, Inc. · Stock Purchase
$1,001 - $15,000
Mar 27, 2025 Feb 25, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Common Stock Purchase
$1,001 - $15,000
Mar 6, 2025 Feb 25, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Stock Purchase
$1,001 - $15,000
Mar 6, 2025 Feb 19, 2025 Filing ↗
Julie JohnsonJulie JohnsonHouse · D · TX MRNAModerna, Inc. · Stock Sale
$1,001 - $15,000
Feb 12, 2025 Jan 15, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRNAModerna, Inc. · Common Stock Sale
$1,001 - $15,000
Feb 6, 2025 Jan 17, 2025 Filing ↗

Whale Activity

Position changes in MRNA reported for 2026-09-30 by 1121 institutional filers
Increased: 298New: 329Held: 114Decreased: 259Closed: 68No prior filing: 53
  • Increased298
  • New329
  • Held114
  • Decreased259
  • Closed68
  • No prior filing53
FilerSharesValueChange
FMR LLC59.0M$11.35Bincreased
BlackRock, Inc.27.8M$5.35Bdecreased
VANGUARD CAPITAL MANAGEMENT LLC23.9M$4.61Bincreased
Capital World Investors22.6M$4.36Bincreased
VANGUARD PORTFOLIO MANAGEMENT LLC15.8M$3.04Bincreased
STATE STREET CORP15.5M$2.98Bdecreased
BAILLIE GIFFORD & CO11.4M$2.20Bdecreased
GEODE CAPITAL MANAGEMENT, LLC10.2M$1.97Bincreased
PRICE T ROWE ASSOCIATES INC /MD/7.6M$1.47Bincreased
Theleme Partners LLP6.7M$1.28Bdecreased
MORGAN STANLEY6.0M$1.16Bdecreased
GOLDMAN SACHS GROUP INC5.9M$1.14Bincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by MRNA insiders, by quarter · Form 4
-1.0M-500.0K0500.0K1.0M2025 Q1: 191.9K2025 Q12025 Q2: -3122025 Q22025 Q3: 02025 Q32025 Q4: -24.4K2025 Q42026 Q1: -173.9K2026 Q12026 Q2: -125.1K2026 Q22026 Q3: -671.5K2026 Q32026 Q4: -156.7K2026 Q4

Recent Insider Transactions

4,031 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Hoge StephenPresident Sale −5,082 $212.57 $1.1M Nov 17, 2026 Form 4 ↗
Hoge StephenPresident Sale −34.0K $211.45 $7.2M Nov 17, 2026 Form 4 ↗
Hoge StephenPresident Sale −157 $214.19 $34K Nov 17, 2026 Form 4 ↗
Hoge StephenPresident Sale −39.2K $219.66 $8.6M Nov 16, 2026 Form 4 ↗
Hoge StephenPresident Sale −39.1K $220.72 $8.6M Oct 15, 2026 Form 4 ↗
Hoge StephenPresident Sale −450 $214.15 $96K Oct 14, 2026 Form 4 ↗
Hoge StephenPresident Sale −38.8K $213.47 $8.3M Oct 14, 2026 Form 4 ↗
Hoge StephenPresident Sale −40.3K $146.07 $5.9M Sep 15, 2026 Form 4 ↗
Hoge StephenPresident Option exercise +76.5K $12.21 $933K Sep 15, 2026 Form 4 ↗
Hoge StephenPresident Sale −40.3K $144.13 $5.8M Sep 14, 2026 Form 4 ↗
Hoge StephenPresident Option exercise +76.5K $12.21 $933K Sep 14, 2026 Form 4 ↗
Mock James MChief Financial Officer Sale −15.0K $134.49 $2.0M Sep 10, 2026 Form 4 ↗
Mock James MChief Financial Officer Sale −19.8K $134.49 $2.7M Sep 10, 2026 Form 4 ↗
Mock James MChief Financial Officer Option exercise +19.8K $30.96 $614K Sep 10, 2026 Form 4 ↗
Mock James MChief Financial Officer Tax withholding −5,704 $148.87 $849K Sep 4, 2026 Form 4 ↗
Mock James MChief Financial Officer Option exercise +11.8K — — Sep 4, 2026 Form 4 ↗
Klinger Shannon ThymeChief Legal Officer Tax withholding −5,704 $148.87 $849K Sep 4, 2026 Form 4 ↗
Klinger Shannon ThymeChief Legal Officer Option exercise +11.8K — — Sep 4, 2026 Form 4 ↗
Klinger Shannon ThymeChief Legal Officer Tax withholding −1,048 $140.34 $147K Sep 1, 2026 Form 4 ↗
Klinger Shannon ThymeChief Legal Officer Option exercise +2,166 — — Sep 1, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding MRNA · SEC Form N-PORT
FundSharesValue% of fundAs of
Growth Fund of America15.0M$2.10B0.60%Aug 31, 2026
Fidelity Growth Company Fund
Fidelity Mt. Vernon Street Trust
8.2M$1.16B1.18%Aug 31, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
11.3M$793.6M0.03%Jun 30, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
4.6M$643.3M0.07%Aug 31, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
9.2M$641.1M0.04%Jun 30, 2026
VANGUARD INTERNATIONAL GROWTH FUND
VANGUARD WORLD FUND
4.3M$603.1M1.35%Aug 31, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
8.2M$573.6M0.30%Jun 30, 2026
VANGUARD SMALL-CAP VALUE INDEX FUND
VANGUARD INDEX FUNDS
5.2M$363.3M0.54%Jun 30, 2026
iShares Core S&P 500 ETF
iShares Trust
4.9M$340.1M0.04%Jun 30, 2026
Fidelity Growth Company K6 Fund
Fidelity Mt. Vernon Street Trust
2.4M$332.6M1.18%Aug 31, 2026

Mutual funds and ETFs whose N-PORT filings list MRNA's shares (CUSIP 60770K107), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 58.9M shares14.8%
    Nov 5, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 58.9M shares14.8%
    Nov 5, 2026 · ↗
  • Capital World InvestorsSCHEDULE 13G · passive (13G) · 22.3M shares5.6%
    Aug 12, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 51.8M shares13.1%
    Aug 6, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 51.8M shares13.1%
    Aug 6, 2026 · ↗
  • BAILLIE GIFFORD & COSCHEDULE 13G/A · passive (13G) · 18.2M shares4.6%
    Jul 24, 2026 · ↗
  • Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 25.9M shares6.5%
    Apr 30, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming moderna as client
$0$250K$500K$750K$1.0M2023 Q1: $50K2023 Q2: $50K2023 Q3: $50K2023 Q4: $50K20232024 Q1: $90K2024 Q2: $50K2024 Q3: $60K2024 Q4: $170K20242025 Q1: $130K2025 Q2: $190K2025 Q3: $370K2025 Q4: $200K20252026 Q1: $260K2026 Q2: $360K2026 Q3: $140K2026
  • AVENUE SOLUTIONSMODERNA, INC. · 2026 Q3 · HCR$50K
    Filing ↗
  • MODERNA, INC.MODERNA, INC. · 2026 Q3 · HCR$70K
    Filing ↗
  • HOLLAND & KNIGHT LLPMODERNA, INC. · 2026 Q3 · TAX$20K
    Filing ↗
  • AVENUE SOLUTIONSMODERNA, INC. · 2026 Q2 · HCR$50K
    Filing ↗
  • MODERNA, INC.MODERNA, INC. · 2026 Q2 · HCR$290K
    Filing ↗

Government Contracts

Federal awards to Moderna, Inc. · USAspending

No federal contract awards found for Moderna, Inc..

U.S. Patents

Recent USPTO applications naming Moderna, Inc.

No USPTO patent applications found for Moderna, Inc..

Annual Financials

From MRNA's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$1.94B$3.24B$6.85B$19.26B$18.47B
Operating income-$3.07B-$3.94B-$4.24B$9.42B$13.30B
Net income-$2.82B-$3.56B-$4.71B$8.36B$12.20B
Diluted EPS-$7.26-$9.28-$12.33$20.12$28.29
Operating cash flow-$1.87B-$3.00B-$3.12B$4.98B$13.62B
Cash and equivalents$2.60B$1.93B$2.91B$3.21B$6.85B
Total assets$12.34B$14.14B$18.43B$25.86B$24.67B
Total liabilities$3.69B$3.24B$4.57B$6.74B$10.52B
Shareholders' equity$8.65B$10.90B$13.85B$19.12B$14.14B

As Moderna, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 20, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in MRNA's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationNov 16, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 9.01Officer / director changeNov 13, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsNov 6, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureSep 30, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 2.03, 3.02, 8.01, 9.01Material agreement · Direct financial obligation · Unregistered sale of equitySep 1, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsJul 31, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureJul 8, 2026
    EDGAR ↗
  • 8-K · Items 5.03, 5.07, 9.01Bylaw amendment · Shareholder voteMay 11, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 1, 2026
    EDGAR ↗

About Moderna, Inc.

From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersCAMBRIDGE, MA
IncorporatedDE
Former namesModerna Therapeutics, Inc.